Long-term outcomes of transcutaneous retrobulbar amphotericin B in COVID-19-associated mucormycosis
Indian Journal of Ophthalmology · 2023
DOI: 10.4103/ijo.ijo_1382_22 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Ophthalmology, 2023. Verfasst von Syed Wajahat A Rizvi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Ophthalmology, Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh, Uttar Pradesh, India. Hauptthemen laut MEDLINE: Mucormycosis, COVID-19, Orbital Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Purpose
To describe the long-term outcomes of transcutaneous retrobulbar amphotericin B (TRAMB) in COVID-19-associated mucormycosis.
Methods
In total, 18 cases of COVID-19-associated mucormycosis were reviewed. In addition to the recommended treatment protocol, all patients were to be given 3.5 mg/ml/day of TRAMB for five days.
Results
Of the 18 patients, 2 presented with stage 3a disease, 13 had stage 3c disease, and 3 patients had central nervous system (CNS) involvement (stage 4a and 4c). In addition to planned retrobulbar doses, five patients were given more while two patients received fewer injections (i.e.,
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Ophthalmology, Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh, Uttar Pradesh, India.
- Department of Ophthalmology, Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh, Uttar Pradesh, India.
- Department of Radiology, Jawaharlal Nehru Medical College, AMU, Aligarh, India.
Zitieren
APA
Rizvi, S. W. A., Khan, S., Shahbaz, M., Gounder, M. S., Saif, M., & Khalid, S. (2023). Long-term outcomes of transcutaneous retrobulbar amphotericin B in COVID-19-associated mucormycosis. Indian Journal of Ophthalmology. https://doi.org/10.4103/ijo.ijo_1382_22
Vancouver
Rizvi SWA, Khan S, Shahbaz M, Gounder MS, Saif M, Khalid S. Long-term outcomes of transcutaneous retrobulbar amphotericin B in COVID-19-associated mucormycosis. Indian Journal of Ophthalmology. 2023. doi:10.4103/ijo.ijo_1382_22
BibTeX
@article{Rizvi2023,
author = {Rizvi, Syed Wajahat A and Khan, Shagil and Shahbaz, Mohammad and Gounder, M Srinivasan and Saif, Mohd and Khalid, Saifullah},
title = {Long-term outcomes of transcutaneous retrobulbar amphotericin B in COVID-19-associated mucormycosis},
journal = {Indian Journal of Ophthalmology},
year = {2023},
doi = {10.4103/ijo.ijo_1382_22}
}
EUVIMED